Pfizer Could Prove Underrated GLP-1 Stock Opportunity
Pfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
Learn why stock market indices matter for benchmark reporting, performance comparison, and portfolio context in everyday investing.
28,349 articlesPfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
When a pharma giant pays more than double a target’s value, the move sends shockwaves through investors. This article...
Jim Cramer signals a clear pecking order in payments, naming Klarna as the one to avoid while highlighting Affirm and...
SanDisk announced a $1 billion strategic equity investment in Nanya Technology, prompting a roughly 6% share decline ...
Intel Arrow Lake Refresh introduces budget-friendly CPUs with stronger cores, bigger caches, and aggressive pricing. ...
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
On Thursday, a wave of fresh analyst calls hit Wall Street, lifting some growth names and trimming others as traders ...
Amazon's AI hardware strategy could extend far beyond cloud services. This article explains how Trainium and Inferent...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
A veteran portfolio manager recounts selling a 19-bagger too early and explains how that misstep reshaped his long-te...
This article delivers a practical, numbers-driven view of aurora (AUR) 2026 earnings. Learn the drivers, risks, and w...
Hedge fund veteran Michael Burry has added stakes in a high-dividend pharma name and a leading oilfield services comp...